SEMA3E and allergic asthma: Sema3E deficiency in mice leads to exaggerated allergic airway inflammation, remodelling, and airway hyperresponsiveness, while intranasal recombinant Sema3E treatment reduced house dust mite-induced allergic asthma (25, 26).